vs
Side-by-side financial comparison of CALERES INC (CAL) and EXELIXIS, INC. (EXEL). Click either name above to swap in a different company.
CALERES INC is the larger business by last-quarter revenue ($790.1M vs $598.7M, roughly 1.3× EXELIXIS, INC.). EXELIXIS, INC. runs the higher net margin — 40.8% vs 0.3%, a 40.5% gap on every dollar of revenue. On growth, CALERES INC posted the faster year-over-year revenue change (6.6% vs 5.6%). EXELIXIS, INC. produced more free cash flow last quarter ($332.4M vs $-12.4M). Over the past eight quarters, EXELIXIS, INC.'s revenue compounded faster (18.7% CAGR vs 6.5%).
Caleres Inc. is an American footwear company that owns and operates a variety of footwear brands. Its headquarters is located in Clayton, Missouri, a suburb of St. Louis. The company was founded in 1878 as Bryan, Brown & Company in St. Louis, though it underwent several name changes. The Hamilton-Brown Shoe Company was the largest manufacturer of shoes in America in the early 20th century, but it went bankrupt in June 1939.
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
CAL vs EXEL — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $790.1M | $598.7M |
| Net Profit | $2.4M | $244.5M |
| Gross Margin | 41.8% | 95.6% |
| Operating Margin | 1.5% | 39.3% |
| Net Margin | 0.3% | 40.8% |
| Revenue YoY | 6.6% | 5.6% |
| Net Profit YoY | -94.2% | 74.8% |
| EPS (diluted) | $0.07 | $0.89 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $598.7M | ||
| Q4 25 | $790.1M | $597.8M | ||
| Q3 25 | $658.5M | $568.3M | ||
| Q2 25 | $614.2M | $555.4M | ||
| Q1 25 | $639.2M | $566.8M | ||
| Q4 24 | $740.9M | — | ||
| Q3 24 | $683.3M | $539.5M | ||
| Q2 24 | $659.2M | $637.2M |
| Q1 26 | — | $244.5M | ||
| Q4 25 | $2.4M | $193.6M | ||
| Q3 25 | $6.7M | $184.8M | ||
| Q2 25 | $6.9M | $159.6M | ||
| Q1 25 | $4.9M | $139.9M | ||
| Q4 24 | $41.4M | — | ||
| Q3 24 | $30.0M | $118.0M | ||
| Q2 24 | $30.9M | $226.1M |
| Q1 26 | — | 95.6% | ||
| Q4 25 | 41.8% | 96.9% | ||
| Q3 25 | 43.4% | 96.6% | ||
| Q2 25 | 45.4% | 96.5% | ||
| Q1 25 | 43.0% | 96.5% | ||
| Q4 24 | 44.1% | — | ||
| Q3 24 | 45.5% | 96.8% | ||
| Q2 24 | 46.9% | 97.2% |
| Q1 26 | — | 39.3% | ||
| Q4 25 | 1.5% | 39.6% | ||
| Q3 25 | 1.4% | 37.6% | ||
| Q2 25 | 1.9% | 33.6% | ||
| Q1 25 | 1.2% | 28.8% | ||
| Q4 24 | 7.7% | — | ||
| Q3 24 | 6.2% | 25.2% | ||
| Q2 24 | 6.5% | 43.3% |
| Q1 26 | — | 40.8% | ||
| Q4 25 | 0.3% | 32.4% | ||
| Q3 25 | 1.0% | 32.5% | ||
| Q2 25 | 1.1% | 28.7% | ||
| Q1 25 | 0.8% | 24.7% | ||
| Q4 24 | 5.6% | — | ||
| Q3 24 | 4.4% | 21.9% | ||
| Q2 24 | 4.7% | 35.5% |
| Q1 26 | — | $0.89 | ||
| Q4 25 | $0.07 | $0.69 | ||
| Q3 25 | $0.20 | $0.65 | ||
| Q2 25 | $0.21 | $0.55 | ||
| Q1 25 | $0.17 | $0.47 | ||
| Q4 24 | $1.19 | — | ||
| Q3 24 | $0.85 | $0.40 | ||
| Q2 24 | $0.88 | $0.77 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $1.1B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $616.8M | $2.2B |
| Total Assets | $2.1B | $2.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.1B | ||
| Q4 25 | $34.0M | $988.5M | ||
| Q3 25 | $191.5M | $791.1M | ||
| Q2 25 | $33.1M | $1.0B | ||
| Q1 25 | $29.6M | $1.1B | ||
| Q4 24 | $33.7M | — | ||
| Q3 24 | $51.8M | $1.2B | ||
| Q2 24 | $30.7M | $1.0B |
| Q1 26 | — | $2.2B | ||
| Q4 25 | $616.8M | $2.2B | ||
| Q3 25 | $613.3M | $2.0B | ||
| Q2 25 | $605.2M | $2.1B | ||
| Q1 25 | $599.0M | $2.2B | ||
| Q4 24 | $598.3M | — | ||
| Q3 24 | $606.1M | $2.3B | ||
| Q2 24 | $570.3M | $2.1B |
| Q1 26 | — | $2.8B | ||
| Q4 25 | $2.1B | $2.8B | ||
| Q3 25 | $2.2B | $2.7B | ||
| Q2 25 | $1.9B | $2.8B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.0B | $3.0B | ||
| Q2 24 | $1.9B | $2.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.2M | $333.5M |
| Free Cash FlowOCF − Capex | $-12.4M | $332.4M |
| FCF MarginFCF / Revenue | -1.6% | 55.5% |
| Capex IntensityCapex / Revenue | 1.4% | 0.2% |
| Cash ConversionOCF / Net Profit | -0.50× | 1.36× |
| TTM Free Cash FlowTrailing 4 quarters | $14.4M | $875.8M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $333.5M | ||
| Q4 25 | $-1.2M | $290.3M | ||
| Q3 25 | $47.3M | $49.0M | ||
| Q2 25 | $-5.7M | $211.4M | ||
| Q1 25 | $28.7M | $240.3M | ||
| Q4 24 | $-39.8M | — | ||
| Q3 24 | $79.6M | $271.3M | ||
| Q2 24 | $36.1M | $119.5M |
| Q1 26 | — | $332.4M | ||
| Q4 25 | $-12.4M | $288.8M | ||
| Q3 25 | $35.0M | $46.2M | ||
| Q2 25 | $-26.2M | $208.5M | ||
| Q1 25 | $18.0M | $236.3M | ||
| Q4 24 | $-57.4M | — | ||
| Q3 24 | $68.5M | $263.1M | ||
| Q2 24 | $26.3M | $113.0M |
| Q1 26 | — | 55.5% | ||
| Q4 25 | -1.6% | 48.3% | ||
| Q3 25 | 5.3% | 8.1% | ||
| Q2 25 | -4.3% | 37.5% | ||
| Q1 25 | 2.8% | 41.7% | ||
| Q4 24 | -7.7% | — | ||
| Q3 24 | 10.0% | 48.8% | ||
| Q2 24 | 4.0% | 17.7% |
| Q1 26 | — | 0.2% | ||
| Q4 25 | 1.4% | 0.2% | ||
| Q3 25 | 1.9% | 0.5% | ||
| Q2 25 | 3.3% | 0.5% | ||
| Q1 25 | 1.7% | 0.7% | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 1.6% | 1.5% | ||
| Q2 24 | 1.5% | 1.0% |
| Q1 26 | — | 1.36× | ||
| Q4 25 | -0.50× | 1.50× | ||
| Q3 25 | 7.05× | 0.27× | ||
| Q2 25 | -0.81× | 1.32× | ||
| Q1 25 | 5.82× | 1.72× | ||
| Q4 24 | -0.96× | — | ||
| Q3 24 | 2.66× | 2.30× | ||
| Q2 24 | 1.17× | 0.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAL
| Brand Portfolio | $383.7M | 49% |
| Landed Wholesale | $148.1M | 19% |
| Wholesale E Commerce | $75.0M | 9% |
| Ecommerce | $68.8M | 9% |
| Stuart Weitzman Brand | $45.8M | 6% |
| Landed Wholesale Ecommerce Drop Ship | $30.6M | 4% |
| First Cost Wholesale | $14.9M | 2% |
| Clt Brand Solutions | $10.2M | 1% |
| License And Royalty | $2.1M | 0% |
EXEL
| Cabometyx | $544.7M | 91% |
| Collaboration | $52.1M | 9% |
| Collaborative Arrangementwith Takeda | $5.9M | 1% |
| Cometriq | $1.8M | 0% |
